Related references
Note: Only part of the references are listed.Advances in the computational development of DNA methyltransferase inhibitors
Jose L. Medina-Franco et al.
DRUG DISCOVERY TODAY (2011)
Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach
Jose L. Medina-Franco et al.
MOLECULAR DIVERSITY (2011)
Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation
Dirk Kuck et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Design, synthesis, inhibitory activity, and binding mode study of novel DNA methyltransferase 1 inhibitors
Takayoshi Suzuki et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer
Mathilde Bayet-Robert et al.
CANCER BIOLOGY & THERAPY (2010)
Solving the Dnmt2 enigma
Matthias Schaefer et al.
CHROMOSOMA (2010)
Novel Inhibitors of Dengue Virus Methyltransferase: Discovery by in Vitro-Driven Virtual Screening on a Desktop Computer Grid
Michael Podvinec et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Cortical DNA methylation maintains remote memory
Courtney A. Miller et al.
NATURE NEUROSCIENCE (2010)
The Universal Protein Resource (UniProt) in 2010
Rolf Apweiler et al.
NUCLEIC ACIDS RESEARCH (2010)
Implications of fast-time scale dynamics of human DNA/RNA cytosine methyltransferases (DNMTs) for protein function
David A. Evans et al.
THEORETICAL CHEMISTRY ACCOUNTS (2010)
Curcumin is a potent DNA hypomethylation agent
Zhongfa Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Molecular Modeling and Molecular Dynamics Studies of Hydralazine with Human DNA Methyltransferase 1
Narender Singh et al.
CHEMMEDCHEM (2009)
Epigenetics, oxidative stress, and Alzheimer disease
Nasser H. Zawia et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Novel Method for Generating Structure-Based Pharmacophores Using Energetic Analysis
Noeris K. Salam et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Energetic analysis of fragment docking and application to structure-based pharmacophore hypothesis generation
Kathryn Loving et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2009)
Modulation of DNA Methylation by a Sesquiterpene Lactone Parthenolide
Zhongfa Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Phase II trial of curcumin in patients with advanced pancreatic cancer
Navneet Dhillon et al.
CLINICAL CANCER RESEARCH (2008)
Anticancer drug discovery targeting DNA hypermethylation
Niefang Yu et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Comparison of composer and ORCHESTRAR
Michael A. Dolan et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2008)
Human DNMT2 methylates tRNAAsp molecules using a DNA methyltransferase-like catalytic mechanism
Tomasz P. Jurkowski et al.
RNA (2008)
Mammalian DNA methyltransferases: A structural perspective
Xiaodong Cheng et al.
STRUCTURE (2008)
Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU)
Jan H. Beumer et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
DNA methylation inhibitor 5-aza-2 '-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B
Stela S. Palii et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Mahanine reverses an epigenetically silenced tumor suppressor gene RASSF1A in human prostate cancer cells
Shankar Jagadeesh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors
Kim Appleton et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
M. Candelaria et al.
ANNALS OF ONCOLOGY (2007)
Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression
Stuart A. Scott et al.
EXPERIMENTAL HEMATOLOGY (2007)
Pharmacokinetics, metabolism, and oral bioavailability of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine in mice
Jan H. Beumer et al.
CLINICAL CANCER RESEARCH (2006)
Effect of procaine hydrochloride on the micellization of double tailed surfactants in the aqueous solution
Jin Zhang et al.
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS (2006)
Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura
David S. Schrump et al.
CLINICAL CANCER RESEARCH (2006)
Mahanine inhibits growth and induces apoptosis in prostate cancer cells through the deactivation of aid and activation of caspases
Swati Sinha et al.
PROSTATE (2006)
Decitabine improves patient outcomes in myelodysplastic syndromes - Resuits of a Phase III randomized study
H Kantarjian et al.
CANCER (2006)
Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications
NT Zaveri
LIFE SCIENCES (2006)
Synthesis and in vitro evaluation of biotinylated RG108: A high affinity compound for studying binding interactions with human DNA methyltransferases
E Schirrmacher et al.
BIOCONJUGATE CHEMISTRY (2006)
Hydralazine target:: From blood vessels to the epigenome
C Arce et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
Discovery of two novel, small-molecule inhibitors of DNA methylation
P Siedlecki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Methylation of tRNAAsP by the DNA methyltransferase homolog Dnmt2
MG Goll et al.
SCIENCE (2006)
The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro
A. J. Steele et al.
LEUKEMIA (2006)
Hydralazine is a powerful inhibitor of peroxynitrite formation as a possible explanation for its beneficial effects on prognosis in patients with congestive heart failure
A Daiber et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Procainamide is a specific inhibitor of DNA methyltransferase 1
BH Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids
WJ Lee et al.
MOLECULAR PHARMACOLOGY (2005)
DNA methylation and human disease
KD Robertson
NATURE REVIEWS GENETICS (2005)
Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases
B Brueckner et al.
CANCER RESEARCH (2005)
Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells
T Ben-Kasus et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Plasma pharmacokinetics, oral bioavailability, and interspecies scaling of the DNA methyltransferase inhibitor, zebularine
JL Holleran et al.
CLINICAL CANCER RESEARCH (2005)
A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes -: art. no. 44
P Zambrano et al.
BMC CANCER (2005)
FDA drug approval summary:: Azacitidine (5-azacytidine, Vidaza™) for injectable suspension
E Kaminskas et al.
ONCOLOGIST (2005)
Biochemistry and biology of mammalian DNA methyltransferases
A Hermann et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer
EA Curry et al.
INVESTIGATIONAL NEW DRUGS (2004)
Preferential response of cancer cells to zebularine
JC Cheng et al.
CANCER CELL (2004)
Role of cysteine residues of p65/NF-κB on the inhibition by the sesquiterpene lactone parthenolide and-N-ethyl maleimide, and on its transactivating potential
AJ Garcia-Piñeres et al.
LIFE SCIENCES (2004)
DNA methyltransferase inhibitors: old and new drugs for an epigenetic cancer therapy
B Brueckner et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Establishment and functional validation of a structural homology model for human DNA methyltransferase 1
P Siedlecki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Zebularine: A novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases
L Zhou et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IκB kinase
BHB Kwok et al.
CHEMISTRY & BIOLOGY (2001)
Share Paper
